Louisville-based KentuckyOne Health, the hospital’s owner, revealed plans to sell Jewish Hospital in May 2017, citing “significant challenges” in the healthcare industry. In December 2017, the health system said it entered exclusive negotiations with BlueMountain Capital Management, a New York investment firm. However, the two parties have not reached an agreement.
The U of Louisville’s academic affiliation agreement with KentuckyOne Health expires at the end of the year, and as ownership questions linger, the university said it doesn’t expect to renew the deal. As a result, the university is planning to move six clinical programs housed at Jewish Hospital to different facilities.
The clinical programs that would move are cardiology, cardiovascular and thoracic surgery, gastroenterology, neurosurgery, organ transplant, and physical medicine and rehabilitation.
“Given the current uncertainty around Jewish Hospital, we have begun a process of transitioning service lines to University of Louisville Hospital and elsewhere,” said U of Louisville President Neeli Bendapudi, adding that they are establishing an “operational transition plan.”
There is no timeline for the moves, likely to face significant regulatory hurdles.
More articles on physician integration issues:
Everything about scheduling patients and doctors today is wrong, and how to fix it
7 things to know about the 2019 Physician Fee Schedule Final Rule
Physicians respond after NRA tells ‘self-important anti-gun doctors to stay in their lane’
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
